Phospho-ERK1/2 levels in cancer cell nuclei predict responsiveness to radiochemotherapy of rectal adenocarcinoma.
about
Chemoradiotherapy and concurrent radiofrequency thermal therapy to treat primary rectal cancer and prediction of treatment responses.Downregulation of dual-specificity phosphatase 4 enhances cell proliferation and invasiveness in colorectal carcinomas.The first thermic treatment predicts following chemoradiation response with concurrent thermal therapy for the treatment of rectal cancer.
P2860
Phospho-ERK1/2 levels in cancer cell nuclei predict responsiveness to radiochemotherapy of rectal adenocarcinoma.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Phospho-ERK1/2 levels in cance ...... rapy of rectal adenocarcinoma.
@ast
Phospho-ERK1/2 levels in cance ...... rapy of rectal adenocarcinoma.
@en
type
label
Phospho-ERK1/2 levels in cance ...... rapy of rectal adenocarcinoma.
@ast
Phospho-ERK1/2 levels in cance ...... rapy of rectal adenocarcinoma.
@en
prefLabel
Phospho-ERK1/2 levels in cance ...... rapy of rectal adenocarcinoma.
@ast
Phospho-ERK1/2 levels in cance ...... rapy of rectal adenocarcinoma.
@en
P2093
P2860
P356
P1433
P1476
Phospho-ERK1/2 levels in cance ...... rapy of rectal adenocarcinoma.
@en
P2093
Lars-Inge Larsson
Niels Pedersen
Susanne Holck
P2860
P304
34321-34328
P356
10.18632/ONCOTARGET.5761
P407
P577
2015-09-21T00:00:00Z